Results 181 to 190 of about 2,484 (221)

The diverse influences of relaxin-like peptide family on tumor progression: Potential opportunities and emerging challenges. [PDF]

Heliyon
Jung J, Han H.
europepmc   +1 more source

Role of <i>Chlorophytum Borivilianum</i> extract against Doxorubicin- induced Myocardial Toxicity in Albino Rats: <i>Insilico</i> and <i>Invivo</i> studies. [PDF]

Arch Razi Inst
Nimbal SK, Nagashettikoppa K, Jeedi NM, Patil SB, Mali N.   +4 more
europepmc   +1 more source

Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades. [PDF]

Expert Opin Ther Pat
Rahman MT, Chaminda Lakmal HH, Hussain J, Jin C.   +3 more
europepmc   +1 more source

Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions. [PDF]

Biochem Pharmacol
Nourmahnad A, Javad Shariyate M, Khak M, Grinstaff MW, Nazarian A, Rodriguez EK.   +5 more
europepmc   +1 more source

Revealing the endocrine landscape of INSL3/RXFP2 signaling in hamster. [PDF]

PLoS One
Ruiz A, Ramos L.
europepmc   +1 more source

Relaxin Modulates the Genomic Actions and Biological Effects of Estrogen in the Myometrium.

Endocrinology
Tripathy S, Nagari A, Chiu SP, Nandu T, Camacho CV, Mahendroo M, Kraus WL.   +6 more
europepmc   +1 more source

Transcriptomic Profiles from Stereo-EEGs May Reflect the Local Brain Cell Microenvironment in Human Epilepsy. [PDF]

Biomolecules
Larkin J, Dwivedi AK, Mahesh A, Sanfeliu A, Sweeney KJ, O'Brien DF, Tiwari VK, Widdess-Walsh P, Henshall DC.   +8 more
europepmc   +1 more source

Serum YKL-40, but Not Relaxin-2, Shows Diagnostic Utility as an Adjunct Biomarker in Colorectal Cancer. [PDF]

Int J Mol Sci
Safiejko K, Juchimiuk M, Doroszkiewicz J, Mroczko B, Zajkowska M.   +4 more
europepmc   +1 more source

Doppler ultrasonographic scan, gene expression and serum profile of immune, APPs and antioxidant markers in Egyptian buffalo-cows with clinical endometritis. [PDF]

Sci Rep
El-Sayed A, Refaai M, Ateya A.
europepmc   +1 more source

Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension. [PDF]

Sci Rep
Zhang SS, Larrabee L, Chang AH, Desai S, Sloan L, Wang X, Wu Y, Parvez N, Amaratunga K, Hartman AC, Whitnall A, Mason J, Barton NP, Chu AY, Davitte JM, Csakai AJ, Tibbetts CV, Tolbert AE, O'Keefe H, Polanco J, Foley J, Kmett C, Kehler J, Kozejova G, Wang F, Mayer AP, Koenig P, Foletti D, Pitts SJ, Schnackenberg CG.   +29 more
europepmc   +1 more source